What is the Treatment for Dry Macular Degeneration?

Table of Contents

What is the Treatment for Dry Macular Degeneration?

Dry AMD begins when protein clumps called drusen form beneath the retina, gradually growing larger over time to damage the macula (geographic atrophy).

One of the early indicators of dry macular degeneration is blurred vision, caused by less functioning cells within the macula. Lighting may help decrease this sensation; sometimes bright light helps clear it away.

Fluorescein angiography

Fluorescein angiography is used by eye doctors to photograph the blood vessels of the retina. This noninvasive test does not damage or harm your eye in any way; rather, fluorescein is injected directly into your bloodstream through either arm or hand and highlights blood vessels of both retina and choroid layers – two layers at the back of your eye that contain vital tissue for vision and eye disease detection such as age-related macular degeneration, diabetic retinopathy, retinal vein occlusion/artery occlusion/ cystoid macular edema/ tumors of back of eye tumors of back of eye tumors of back of eye tumors of back of eye tumors of back of eye tumors of back of eye tumors of back of eye tumors of back of eye tumors in back of eye tumors of back of eye tumors of back of eye tumors of back of eye tumors of back of eye tumors in back of eye diseases such as age-related macular degeneration; diabetic retinopathy; retinal vein occlusion/artery occlusion/ cystoid macular edema and tumors on back side. This test may provide information such as age related macular degeneration, diabetic retinopathy retinal vein occlusion/artery occlusion cystoid macular edema cystoid macular area etc. This technique used for tumor diagnosis as well. It serves tumors from cancerous tissues of back of eyes as age related macular degeneration as well as vein/artery occlusion/artery occlusion/artery occlusion/artery occlusion/ cystota tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor tumor growths etc edema cystod macular edema/ cystoma cystomyoedemas/ tumor tumors in back layers of eyes as tumor tumors or tumor tumor growth from back layers of back layers edema/retin.

Dry macular degeneration occurs when light-sensing cells within the macula become damaged and no longer function, leading to central vision loss but not side vision loss. Although its cause remains unknown, macular degeneration may be linked to deposits of fatty waste and minerals called drusen that collect beneath the retina – smoking, high blood pressure, cardiovascular disease and genetic factors all increase your risk for macular degeneration.

If a patient exhibits significant drusen and is at risk of advanced AMD with abnormal new blood vessels (wet form), their ophthalmologist may perform fluorescein angiography. In this test, an orange-red dye is injected into an arm vein before traveling through their bloodstream into their eye where it can be photographed using special equipment to reveal any anomalies such as new vessel growth under their retina.

While dry macular degeneration cannot be reversed, its progression can be reduced by following your ophthalmologist’s advice in eating eye-healthy foods and taking vitamin supplements as instructed by him/her. Furthermore, managing other medical conditions such as high blood pressure and diabetes and refraining from smoking are also vital in managing its progression.

Optical coherence tomography (OCT)

Optic coherence tomography (OCT) is a sophisticated imaging test that employs invisible beams of light to obtain high-resolution images of the retina, making it a vital tool in diagnosing and monitoring patients suffering from macular degeneration, diabetic macular edema and other eye diseases. The test only takes minutes and is noninvasive – providing physicians with greater access to view layers in greater detail as well as any distortions caused by epiretinal membrane or macular hole conditions.

SD-OCT technology has evolved greatly over time, leading to faster scanning speeds, wider fields of view, and better resolution. This method is used to measure retina thickness as well as other vital structures like vitreous cavities; additionally it gives insight into eye vascularity flow patterns.

Drusen are an iconic feature of dry macular degeneration. Made up of extracellular debris deposited between retinal pigment epithelium (RPE) and Bruch’s membrane, they’re visible with conventional color fundus photography; however their ultrastructural properties are hard to interpret as their size, shape and color can differ greatly – typically being surrounded by hyperreflective areas that might represent RPE migration or pigment accumulation. Optical coherence tomography provides more reliable assessment of drusen to determine risk for progression into wet macular degeneration.

Wet AMD is an advanced form of macular degeneration in which abnormal blood vessels form beneath the retina and leak fluid into it from time to time, eventually causing permanent damage in the macula and leading to blurry vision or the possible loss of their central vision. Patients diagnosed with Wet Macular Degeneration typically experience blurry or reduced central vision and experience blurry or clouded vision symptoms as symptoms progress.

Recent SD-OCT research indicates that changes to drusen patterns on OCT can predict new atrophy onset among eyes with non-neovascular age-related macular degeneration (NNVAMD). Researchers evaluated changes to retina thickness, optic nerve head thickness and RPE junction between vitreous and RPE, and the presence of occult choroidal neovascularization (CNVM). They discovered that when an OCT-detected drusenoid lesion transformed from drusenoid to geographic atrophy, macula thickness increased significantly accompanied by changes to the layer of choriocapillaries underneath it and moderate optical back scatter in sub-RPE region with thickening reflective bands of CNVM corresponding to fusiform thickening of reflective bands corresponding to it.

Photodynamic therapy (PDT)

Age-related macular degeneration occurs through thinning and breakdown of the macula, the part of your retina that sees fine details at the center of your visual field. Over eight out of ten people diagnosed with AMD have the dry form, in which deposits of fatty waste and minerals accumulate beneath the retina and lead to macular tissue thinning and central vision gradually worsens, with colors becoming muted or blurry over time. Vision loss from cataracts does not usually impair peripheral (side) vision and typically doesn’t lead to complete blindness in either eye. Dry macular degeneration remains poorly understood; however, its cause appears to be linked to unchecked oxidative stress and its byproducts that damage retinal pigment epithelium leading to the formation of drusen deposits on retina. Certain genetic traits and lifestyle factors, including smoking can increase one’s risk.

Wet macular degeneration is less prevalent, yet more serious. It occurs when abnormal blood vessels form beneath the retina and leak fluid, leading to rapid loss of central vision as well as dark spots within visual fields and reduced peripheral vision.

No cure exists for wet macular degeneration; however, you can take steps to slow its progress. Regular examinations, additional testing, and injection therapy all play an integral part. In addition, follow your physician’s recommendations regarding diet rich in antioxidant vitamins and minerals while managing any additional medical conditions that might aggravate it – like high blood pressure or cardiovascular disease which could contribute to its progression.

Many patients with wet macular degeneration have responded well to treatments using anti-vascular endothelial growth factor (VEGF). When administered intraocularly, these drugs help decrease new blood vessel formation and leakage of fluid from existing vessels, as well as stop further progression of wet AMD. Laser surgery can also be used to destroy abnormal vessels and slow its progress.

Researchers are researching artificial retinas and methods of stimulating the retina that may restore central vision lost due to advanced macular degeneration. While progress in this area of research is certainly encouraging, it’s likely that any central vision lost due to macular degeneration will never be completely recovered.

Laser surgery

Macular degeneration occurs most commonly as dry macular degeneration, the early form of which involves gradual atrophy of the macula that results in central vision being blurry while peripheral vision remains intact. It occurs due to light-sensitive retinal cells within the macula breaking down or dying and leading to fluid leakage and scarring of retina – this can eventually result in permanent blindness in up to 10% of people affected by dry macular degeneration.

Wet macular degeneration (WMD) is more dangerous than dry macular degeneration because it can result in sudden loss of vision within days. WMD develops when abnormal blood vessels grow beneath the retina and leak fluid or blood into it, damaging macula tissue. WMD may begin as dry macular degeneration but also occurs independent of it – accounting for 90% of severe visual loss caused by macular degeneration.

People suffering from wet macular degeneration develop abnormal blood vessels that quickly cause them to lose vision, making early diagnosis essential in helping slow its progress. Regular visits with an eye doctor are crucial in order to detect early stages of this disease and ensure optimal treatment options can be utilized to slow its progress.

Wet macular degeneration can be effectively treated through injecting anti-angiogenesis drugs or anti-VEGF agents into the eye to mitigate damage. These anti-VEGF agents work by inhibiting new abnormal blood vessel growth while slowing leakage of fluid from existing ones. We may also employ laser surgery on certain patients in order to seal off abnormal veins beneath their retina.

Although these treatments cannot restore vision, they can significantly slow the progression of disease and improve quality of life. Furthermore, it’s vital to heed advice from an ophthalmologist on eating healthily, staying physically active, and managing other medical conditions like heart disease or high blood pressure.

About the Author:
Picture of Alexander Suprun

Alexander Suprun

Alex started his first web marketing campaign in 1997 and continues harvesting this fruitful field today. He helped many startups and well-established companies to grow to the next level by applying innovative inbound marketing strategies. For the past 26 years, Alex has served over a hundred clients worldwide in all aspects of digital marketing and communications. Additionally, Alex is an expert researcher in healthcare, vision, macular degeneration, natural therapy, and microcurrent devices. His passion lies in developing medical devices to combat various ailments, showcasing his commitment to innovation in healthcare.

Macular
Degeneration?

Stop It Now...

Related Posts
shop cartShop Best Low-Vision Aids with FREE Doctor Consultation.Yes! Let's Go